No Data
No Data
No Data
【New 5% Rule】: Comprising companies such as Uluru and Canvas.
<241A> Roxx Persol Career Co., Ltd. Representative Director Seo Yutaka Shareholding Percentage - 6.05% Reporting Obligation Date 2024/09/25 Roxx Co., Ltd. Nakajima Taro Shareholding Percentage - 16.63% Reporting Obligation Date 2024/09/25 <246A> Asua Kanjida Co., Ltd. Shareholding Percentage - 58.61% Reporting Obligation Date 2024/09/26 <3979> Stocks
LiberaWare, Fanpep, etc.
<218A> Liberaware Bonds Investment Group Co., Ltd. shareholding ratio 5.16% → 2.94% Reporting obligation start date 09/19/2024 <218A> Liberaware DRONE FUNDS Co., Ltd. shareholding ratio 6.84% → 5.70% Reporting obligation start date 09/19/2024 <241A> ROXX Persol Career Co., Ltd. shareholding ratio
Crowdworks, Lear Pharmaceuticals, and others.
<195A> Acquired the stocks of Matsumura Shoten, which handles original fashion accessories, planning, manufacturing, and sales such as wallets, pouches, and bags for kids and teens, and subsidiary <3646> Acquired all the shares of Otosei, which is engaged in the station search IT solutions business, and made it a wholly-owned subsidiary <3900> Selected as a lease stock for Cloud Works <4579> Obtained approval for the sale of the acid secretion inhibitor, Tegoprazan, a Rakuria drug, in Malaysia <4881> Fanpep 11th
dai, learning aid, etc.
<151A> Dai Go Deere & Co. Capital Singapore Private Limited (Gordian Capital Singapore Private Limited) shareholding ratio 5.05% → 3.96% Reporting obligation date July 9, 2024 <184A> Morgan Stanley And Company LLC (Morgan Stanley & Co. LLC)
Fanpep Research Memo (10): While continuing to withhold dividends for the time being, the increase in corporate value and the return to shareholders through shareholder benefits.
■Fanpep <4881> recognizes the importance of shareholder returns as a key management issue, but currently it is in the development stage and does not pay dividends. Instead, it prioritizes funding for research and development activities, aiming to achieve early monetization and enhance corporate value as the greatest shareholder return. In this regard, the company has implemented a shareholder benefit program with the aim of having many shareholders hold the company's shares in the medium to long term. As for the benefits,
Fanpep Research Memo (8): Sales losses are expected to continue for the time being due to the development stage.
-Fanpep <4881> performance and financial situation 1. Performance trends (1) Summary of cumulative performance for the second quarter of the fiscal year ending December 2024 The consolidated performance for the cumulative second quarter of the fiscal year ending December 2024 was as follows: Operating income was flat compared to the same period last year at 0.5 million yen, operating loss was 395 million yen (loss of 622 million yen), ordinary loss was 382 million yen (loss of 589 million yen), and quarterly net loss attributable to parent company shareholders was 379 million yen (loss of 585 million yen). Operating income is for the cosmetic segment.
No Data
No Data